Cellino at Startup Battlefield Disrupt 2021

Cellino: Pioneering Personalized Cell Therapies

This information was documented on September 22, 2021. Cellino is dedicated to broadening access to personalized, autologous cell therapies for individuals in need.

The Future of Regenerative Medicine

The development of stem cell-based regenerative medicines holds the potential to provide cures for debilitating diseases within the next ten years. Conditions such as Parkinson’s disease, diabetes, and heart disease are key targets for these innovative treatments.

The Advantage of Patient-Specific Cells

Utilizing cells specific to each patient is believed to offer the safest and most impactful therapeutic outcomes. This approach minimizes the risk of rejection and maximizes treatment efficacy.

Cellino’s Innovative Platform

Cellino’s proprietary platform leverages the power of AI-guided lasers. This technology enables the large-scale production of personalized regenerative medicines, representing a significant advancement in the field.

For the first time, it is possible to manufacture these therapies in a way that is both personalized and scalable. This breakthrough promises to accelerate the delivery of these life-changing treatments to a wider patient population.